Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent D Stewart

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|February 9, 2007
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitorsYunsong Tong, Akiyo Claiborne, Kent D Stewart, et al.
Journal of Medicinal Chemistry|March 21, 2007
Discovery and structure-activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitorsZhonghua Pei, Xiaofeng Li, Thomas W von Geldern, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitorsYujia Dai, Kresna Hartandi, Niru B Soni, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2008
Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitorsVijaya Gracias, Zhiqin Ji, Irini Akritopoulou-Zanze, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2006
Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitorsJürgen Dinges, Irini Akritopoulou-Zanze, Lee D Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Isoindolinone ureas: a novel class of KDR kinase inhibitorsMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Biochemistry|January 22, 2003
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor seriesVincent Stoll, Kent D Stewart, Clarence J Maring, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailabilityYunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Journal of Medicinal Chemistry|October 22, 2009
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinasesZhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|February 9, 2007
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitorsYunsong Tong, Akiyo Claiborne, Kent D Stewart, et al.
Journal of Medicinal Chemistry|March 21, 2007
Discovery and structure-activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitorsZhonghua Pei, Xiaofeng Li, Thomas W von Geldern, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitorsYujia Dai, Kresna Hartandi, Niru B Soni, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2008
Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitorsVijaya Gracias, Zhiqin Ji, Irini Akritopoulou-Zanze, et al.
Bioorganic & Medicinal Chemistry Letters|June 6, 2006
Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitorsJürgen Dinges, Irini Akritopoulou-Zanze, Lee D Arnold, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Isoindolinone ureas: a novel class of KDR kinase inhibitorsMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Biochemistry|January 22, 2003
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor seriesVincent Stoll, Kent D Stewart, Clarence J Maring, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailabilityYunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Journal of Medicinal Chemistry|October 22, 2009
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinasesZhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, et al.
Pageof 7